Blood pressure breakthrough? device shows promise for High-Altitude hypertension

NCT ID NCT07562477

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a device that temporarily restricts blood flow to the arms (remote ischemic conditioning) can help lower blood pressure in people with hypertension who moved to high-altitude areas. 184 adults will either continue their usual medication or add the device treatment for 30 days. The goal is to see if the device can safely reduce blood pressure further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

remote ischemic conditioning (RIC) device

What this could lead to

If it works, this could offer a non-drug way to help control blood pressure in people living at high altitudes.

What could go wrong

This is a relatively small, early-phase trial (184 participants) testing a device-based add-on. The effect may be modest or not clinically significant, and results may not apply to other populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.